Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11919868
Heterocyclic compounds and related methods
granted -
US 11919927
Prefusion-stabilized hMPV F proteins
granted -
US 11918571
Compounds and their methods of use
granted -
US 11920139
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
granted -
US 11920134
Compositions and methods for inhibiting expression of RRM2 genes
granted -
US 11911403
Antisense-induced exon exclusion in type VII collagen
granted -
US 11912997
RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use
granted -
US 11912750
GDNF fusion polypeptides and methods of use thereof
granted -
US 11904052
Methods for ameliorating infusion reactions
granted -
US 11897969
Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury
granted -
US 11897875
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders
granted -
US 11891399
Inhibitors of cancer invasion, attachment, and/or metastasis
granted -
US 11885861
3-dimensional representations of post-contrast enhanced brain lesions
granted -
US 11884919
Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene
granted -
US 11884944
Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof
granted -
US 11878998
Prefusion RSV F proteins and their use
granted -
US 11878074
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 11873495
Compounds and methods for reducing LRRK2 expression
granted -
US 11866688
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11866439
Ion channel modulators
granted -
US 11866476
Masked IL-2-Fc fusion polypeptides
granted -
US 11866747
Engineered meganucleases that target human mitochondrial genomes
granted -
US 11866742
Fusion proteins comprising enzyme replacement therapy enzymes
granted -
US 11857697
Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses thereof
granted